HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Alosetron

HCID 2099
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
122852-42-0
Standard SMILES
Cc1[nH]cnc1CN1CCc2c(c3ccccc3n2C)C1=O
InChIKey
JSWZEAMFRNKZNL-UHFFFAOYSA-N
Molecular formula
C17H18N4O
Average molar mass
294.35 g/mol
Monoisotopic mass
294.14806121

Overview

Alosetron is a pyrido[4,3-b]indole compound having a 5-methyl-1H-imidazol-4-ylmethyl group at the 2-position. It has a role as a serotonergic antagonist, an antiemetic and a gastrointestinal drug. It is a member of imidazoles and a pyridoindole.

Names & identifiers

Preferred name
Alosetron
IUPAC
5-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-3,4-dihydropyrido[4,3-b]indol-1-one
English name
Alosetron
Molecular formula
C17H18N4O
Molecular weight
294.35

Names & synonyms

alosetron122852-42-0alosetron monohydrochlorideGR68755GR 68755alosetronum5-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-3,4-dihydropyrido[4,3-b]indol-1-oneA03AE01CHEBI:25334213Z9HTH1152,3,4,5-Tetrahydro-5-methyl-2-((5-methyl-1H-imidazol-4-yl)methyl)-1H-pyrido(4,3-b)indol-1-one1H-Pyrido(4,3-b)indol-1-one, 2,3,4,5-tetrahydro-5-methyl-2-((5-methyl-1H-imidazol-4-yl)methyl)-
Show more names
aloosetron.GR-68755XGR-68755ALOSETRON USP/EP/BPAlosetron (GR-68755XGR 68755XGR-687559-methyl-3-(5-methyl-3H-Imidazol-4-ylmethyl)- 1,2,3,9-Tetrahydro-9-methyl-3-(5-methyl-3H-Imidazol-4-ylmethyl)-1,2,3,9-Tetrahydro-Carbazol-4-One Hydrochloride5-Methyl-2-[(4-methyl-1H-imidazol-5-yl)methyl]-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indol-1-one
DTXSID60442785-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-1H,2H,3H,4H,5H-pyrido[4,3-b]indol-1-one2,3,4,5-Tetrahydro-5-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-1H-pyrido[4,3-b]indol-1-one5-methyl-2-((5-methyl-1H-imidazol-4-yl)methyl)-1H,2H,3H,4H,5H-pyrido(4,3-b)indol-1-one5-methyl-2-((5-methyl-1H-imidazol-4-yl)methyl)-3,4-dihydropyrido(4,3-b)indol-1-oneRefChem:58090DTXCID4024278Lotronex

Properties

Computed structural propertiesFilling in

XLogP
1.6
Topological polar surface area
53.9 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
2
Rotatable bonds
2
Heavy atoms
22
Formal charge
0
Complexity
442

Experimental & physicochemical properties

DrugsPharmaceuticals -> Listed in ZINC15
LogP2
Solubility4.38e-01 g/L
Human DrugsBreast Feeding; Lactation; Gastrointestinal Agents; Serotonin Antagonists;
Physical DescriptionSolid

Physicochemical properties

Melting point
238 · 238-240 °C
Boiling point
648.1 · 648.1±55.0 °C(Predicted)
Density
1.34 · 1.34±0.1 g/cm3(Predicted)
storage temp.
-20 °C · Store at -20°C
solubility
DMSO
pka
14.1 · 14.10±0.10(Predicted)
form
Powder
FDA UNII
13 Z9HTH115 · 13Z9HTH115

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Toxicology

Adverse Effects · 1 item

The most common adverse effect associated with alosetron administration is constipation. A randomized, double-blind, placebo-controlled study assessed the efficacy and safety of alosetron 0.5 mg and 1 mg in women with severe IBS-D. The study data revealed that constipation occurred in patients receiving 0.5 mg (9%), 1 mg once daily (16%), and 1 mg twice daily (19%).

Toxicity SummarySigns and Symptoms of Overdose
Drug Induced Liver Injury · 5 items

Drug-Induced Liver Injury Severity and Toxicity (DILIst)

alosetron

DILI Positive

Oral

DOI:10.1016/j.drudis.2019.09.022

Effects During Pregnancy and Lactation◉ Summary of Use during Lactation

Safety data

risk_code
36/37/38
hazard_code
Xi
safety_code
26-36

Chemistry & industry

Pharmacology

ATC Code · 2 items

A - Alimentary tract and metabolism

QA - Alimentary tract and metabolism

Protein Binding82%
Pharmacodynamics · 1 item

Alosetron is a potent and selective antagonist of the serotonin 5-HT<sub>3</sub> receptor type. Activation of these receptors and the resulting neuronal depolarization affects the regulation of visceral pain, colonic transit, and GI secretions processes that are related to IBS. By blocking these receptors, alosetron is able to effectively control IBS.

Mechanism of Action · 1 item

Alosetron is a potent and selective 5-HT<sub>3</sub> receptor antagonist. 5-HT<sub>3</sub> receptors are nonselective cation channels that are extensively distributed on enteric neurons in the human gastrointestinal tract, as well as other peripheral and central locations. Activation of these channels and the resulting neuronal depolarization affect the regulation of visceral pain, colonic transit and gastrointestinal secretions, processes that relate to the pathophysiology of irritable bowel syndrome (IBS). 5-HT<sub>3</sub> receptor antagonists such as alosetron inhibit activation of non-selective cation channels which results in the modulation of serotonin-sensitive GI motor and sensory processes.

Biological Half-Life1.5 hours
Metabolism/Metabolites · 2 items

Hepatic, via microsomal cytochrome P450 (CYP)

Alosetron has known human metabolites that include 6-hydroxy-5-methyl-2-[(5-methyl-2-oxo-1,3-dihydroimidazol-4-yl)methyl]-3,4-dihydropyrido[4,3-b]indol-1-one and 6-Hydroxy-5-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-3,4-dihydropyrido[4,3-b]indol-1-one.

FDA Pharmacological Classification · 6 items

13Z9HTH115

ALOSETRON

Mechanisms of Action [MoA] - Serotonin 3 Receptor Antagonists

Established Pharmacologic Class [EPC] - Serotonin-3 Receptor Antagonist

Related reactions

21 records
New reaction record
HRID 125219 reaction equation
HRID 125219As product
HRID 297715 reaction equation
HRID 297715As reactant
HRID 484098 reaction equation
HRID 484098As product
HRID 484099 reaction equation
HRID 484099As reactant
HRID 937523 reaction equation
HRID 937523As product
HRID 1197489 reaction equation
HRID 1197489As reactant
HRID 1217666 reaction equation
HRID 1217666As product
HRID 1588272 reaction equation
HRID 1588272As product
PreviousPage 1 of 3

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes

Database identifiers

CAS
122852-42-0
PubChem CID
2099
DTXSID
DTXSID6044278
ChEMBL
CHEMBL1110
ChEBI
CHEBI:253342
UNII
13Z9HTH115
Nikkaji
J532.750D
ATC code
3 AE01 · A03AE01
Hazard Codes
Xi
Risk Statements
36 · 36/37/38
Safety Statements
26 · 26-36

Alosetron is a Serotonin-3 Receptor Antagonist. The mechanism of action of alosetron is as a Serotonin 3 Receptor Antagonist.

ALOSETRON

MeSH Pharmacological Classification · 2 items

Drugs used for their effects on the gastrointestinal system, as to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion.

Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS.

Absorption, Distribution and Excretion · 4 items

50-60 %

Renal elimination of unchanged alosetron accounts for only 6% of the dose. Alosetron is extensively metabolized in humans.

65 to 95 L

600 mL/min

Cellular LocationsMembrane

Applications

UsesAnti-emetic.

Upstream & downstream products

Upstream raw materials

1-Trityl-1H-imidazole-4-methanolSodium hydridepolyphosphoric acidThionyl chlorideMaleic acidHydroxylamine hydrochloride2-Methoxyethanol

Additional notes

DefinitionChEBI: A pyrido[4,3-b]indole compound having a 5-methyl-1H-imidazol-4-ylmethyl group at the 2-position.